The innovative sphere, the main part of science and research works, nowadays is the fundamental factor of qualitative economic growth. At the same time, this sphere requires huge financial and material costs, as well as very high qualification of workers.
In the article “The cost of research work on pre-clinical studies”, published on the website of GMP news, Doctor of Medical Sciences, Professor Valery Makarov, General Director of St. Petersburg Institute of Pharmacy talked about the structure of preclinical study expenses and how the cost of preclinical studies is formed.